PQ 1379
1379. Deputy Bernard J. Durkan asked the Minister for Health the extent to which use of the Single European Market can be identified as a means of alleviating the impact of persons faced with the high cost of experimental drugs; and if he will make a statement on the matter. [28192/17]
Introduced
20 June 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
20 June 2017
Summary
1379. Deputy Bernard J. Durkan asked the Minister for Health the extent to which use of the Single European Market can be identified as a means of alleviating the impact of persons faced with the high cost of experimental drugs; and if he will make a statement on the matter. [28192/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Prices
Medicinal Products Prices
xml · EN · 20 June 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-06-20/1379/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-06-20/pq_1379